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Background: Flavonoids comprise a large family of secondary plant metabolic intermediates that exhibit a wide
variety of antioxidant and human health-related properties. Plant production of flavonoids is limited by the low
productivity and the complexity of the recovered flavonoids. Thus to overcome these limitations, metabolic
engineering of specific pathway in microbial systems have been envisaged to produce high quantity of a single
molecules.
Result: Saccharomyces cerevisiae was engineered to produce the key intermediate flavonoid, naringenin, solely
from glucose. For this, specific naringenin biosynthesis genes from Arabidopsis thaliana were selected by
comparative expression profiling and introduced in S. cerevisiae. The sole expression of these A. thaliana genes
yielded low extracellular naringenin concentrations (<5.5 μM). To optimize naringenin titers, a yeast chassis
strain was developed. Synthesis of aromatic amino acids was deregulated by alleviating feedback inhibition of
3-deoxy-d-arabinose-heptulosonate-7-phosphate synthase (Aro3, Aro4) and byproduct formation was reduced by
eliminating phenylpyruvate decarboxylase (Aro10, Pdc5, Pdc6). Together with an increased copy number of the
chalcone synthase gene and expression of a heterologous tyrosine ammonia lyase, these modifications resulted in a
40-fold increase of extracellular naringenin titers (to approximately 200 μM) in glucose-grown shake-flask cultures. In
aerated, pH controlled batch reactors, extracellular naringenin concentrations of over 400 μM were reached.
Conclusion: The results reported in this study demonstrate that S. cerevisiae is capable of de novo production of
naringenin by coexpressing the naringenin production genes from A. thaliana and optimization of the flux towards
the naringenin pathway. The engineered yeast naringenin production host provides a metabolic chassis for
production of a wide range of flavonoids and exploration of their biological functions.
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In recent years, plant flavonoids, which comprise a family
of over 9000 compounds, have attracted a tremendous
increase in research interest [1-3]. This interest is mainly
attributed to highly promising human health applications
of specific flavonoids [4-8]. The biological activities of
flavonoid compounds have been investigated in relation
to a multitude of human pathological conditions, including
cancer, diabetes, obesity and Parkinson’s disease [6,9-14].* Correspondence: j.g.daran@tudelft.nl
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reproduction in any medium, provided the orThe identified mechanisms of action include scavenging
of oxygen radicals, anti-inflammatory, antiviral and anti-
tumor activities [15,16].
Both for health related research and commercial nutri-
tional applications, availability of sufficient amounts of
defined flavonoid preparations is important. To date, fla-
vonoid production mostly relies on isolation from plants.
However, investigation and subsequential industrialization
from plants is hampered by their low production effi-
ciency. In addition to the low growth rate of some of the
producing plants, extraction and separation of flavonoids
with highly related structures complicate plant-based pro-
duction, thereby impeding progress in the exploration of
the biological activities of flavonoids [13,14]. Although fla-
vonoids can be produced chemically, efficient productionral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the complexity of the molecules, as well as by the neces-
sity of utilizing toxic chemicals and extreme reaction con-
ditions [13,14].
In response to the poor production efficiency from
plants and chemical synthesis, research groups have
directed their attention to the heterologous production
of flavonoids in microorganisms such as Escherichia coli
and Saccharomyces cerevisiae, using metabolic engineer-
ing and synthetic biology [14,17-20]. In plants, formation
of the central metabolite naringenin involves six steps
catalyzed by phenylalanine ammonia lyase (PAL), cinna-
mate 4-hydroxylase (C4H) and its associated cytochrome
P450 reductase (CPR), 4-coumaric acid-CoA ligase (4CL),
chalcone synthase (CHS) and chalcone isomerase (CHI)
(Figure 1) [21,22]. Alternatively, a tyrosine ammonia lyase
(TAL) can convert tyrosine directly to coumaric acid and
circumvent the use of membrane bound P450 related
enzymes, which may pose challenges in E. coli [14,18].
Additionally, in plants, these enzymes and their corre-
sponding genes are often represented by several isoforms,
which may differ in substrate preference or kinetic proper-
ties [23]. Moreover, the different isoforms are proposed
to be organized in one or more enzyme complexes that
may promote substrate channeling. In Arabidopsis thali-
ana, interaction between CHS, CHI and an enzyme
downstream of naringenin, flavonol 3-hydroxylase were
demonstrated based on affinity chromatography and
immunoprecipitation assays [24-26].
Expression of enzyme combinations, originating from
a variety of host organisms has yielded microbial strains
capable of producing the key flavonoid precursor narin-
genin (Figure 1). Several reports describe successful
biotransformation processes in which a phenylpropa-
noid precursor, such as coumaric acid, is converted
into naringenin by metabolically engineered E. coli or
S. cerevisiae [1,14,17,19,20,27,28]. The highest naringenin
titers obtained through biotransformation were achieved
in E. coli, with naringenin titers reaching 1.74 mM
(474 mg·l-1) from 2.6 mM coumaric acid supplied to the
medium [1]. The reliance on ‘expensive’ phenylpropanoid
precursors might represent a major hurdle for economic-
ally feasible flavonoid production[18]. Hitherto, only one
study reports de novo naringenin production from glu-
cose. Using an engineered E. coli strain, naringenin titers
of up to 106.5 μM (29 mg·l-1) were obtained [18].
S. cerevisiae has several attractive characteristics as a
metabolic engineering platform for flavonoid production.
In addition to its excellent accessibility to molecular and
synthetic biology techniques [29,30], its eukaryotic nature
may facilitate functional expression of plant-derived fla-
vonoid-biosynthetic genes. For example, S. cerevisiae can
functionally express cytochrome P450-containing enzymes
and its subcellular compartmentation is comparable tothat of plant cells [31]. Finally, its GRAS (generally
recognized as safe) status facilitates subsequent applica-
tion for the production of pharma- and nutraceuticals.
The goal of the present study was to define a metabolic
engineering strategy for de novo production of naringenin
by S. cerevisiae, using glucose as sole carbon source. For
optimal synergistic activity, the flavonoid biosynthetic
genes PAL1, C4H, CPR1, 4CL3, CHS3 and CHI1 used in
this study were derived from a single plant species,
A. thaliana and selected for in planta co-expression
profiles. After expression of the plant pathway genes,
optimization of naringenin production was explored by
engineering of precursor supply to the naringenin path-
way and by reducing the formation of byproducts derived
from yeast metabolism.
Results
Selection of naringenin biosynthetic genes from
A. thaliana
As a first step towards heterologous expression of narin-
genin in S. cerevisiae, flavonoid biosynthetic genes were
selected from A. thaliana. It has been proposed that, in
plants, flavonoid biosynthetic enzymes can be organized
in protein complexes, where the proteins involved in the
pathway are spatially co-localized. The combination of
isoenzymes in such complexes is hypothesized to facili-
tate the synthesis of different flavonoids [24]. In addition,
complex formation might enhance pathway activity and
carbon flux via metabolic channeling of intermediates
[24]. Moreover, formation of toxic intermediates is kept
locally and are sequentially converted [32]. Protein com-
plex formation is likely to require specific protein-protein
interactions and therefore, co-evolution of the protein
structures of the enzymes that form these complexes.
In A. thaliana, several isoenzymes exist for most of
the reactions leading to naringenin formation (Table 1).
In order to identify the best set of isoenzymes for narin-
genin production and maintain the potential benefit of
plant-specific protein-protein interactions upon expres-
sion in S. cerevisiae, a subset of isoenzymes from one sin-
gle species, A. thaliana, was identified and subsequently
subjected to expression profile correlation analysis. The
subset of isoenzymes was selected based on previous
reports indicating either the involvement in the lignin
biosynthetic pathway [33] and/or the flavonoid biosyn-
thetic pathway (Figure 1), since these pathways share
the same reactions up to the metabolic branch-point
coumaroyl-CoA. The specific genes from this isoenzyme
subset were then further assessed for the correlation of
their expression levels in a dataset comprising 392 tran-
scriptome studies of A. thaliana [34].
From the expression correlation analysis, using the
BAR Expression Angler [35], two clear modules could
be distinguished (Figure 2). The first module comprises
Figure 1 (See legend on next page.)
Koopman et al. Microbial Cell Factories 2012, 11:155 Page 3 of 15
http://www.microbialcellfactories.com/content/11/1/155
(See figure on previous page.)
Figure 1 Schematic representation of the engineered naringenin production pathway in S. cerevisiae. Six A. thaliana genes were
overexpressed: PAL1 (phenylalanine ammonia lyase), C4H (Cinnamate 4-hydroxylase), CPR1 (cytochrome P450 reductase), 4CL3 (4-coumaric
acid-CoA ligase), CHS3 (chalcone synthase) and CHI1 (chalcone isomerase), and one gene from Rhodobacter capsulatus; Tal1 (tyrosine ammonia
lyase). Dashed lines indicate feedback inhibition. Grey arrows indicate the S. cerevisiae pathway for phenylethanol production. Bold dark grey
arrows indicate the naringenin production pathway as described for A. thaliana [22]. Aro3/Aro4: 3-deoxy-D-arabino-heptulosonate-7-phosphate
(DAHP) synthase, Pdc1, 5, 6; pyruvate decarboxylases, Aro10; phenylpyruvate decarboxylase.
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acid-CoA ligase gene (4CL3), the chalcone synthase gene
(CHS3), two chalcone isomerase genes (CHI1, CHI3)
and a number of genes that mediate the further modifi-
cation of naringenin. The second, a lignin module, com-
prised two phenylalanine ammonia lyase (PAL1, PAL2)
genes, the trans-cinnamate 4-monooxygenase (C4H) gene
and three 4-coumaric acid-CoA ligase genes (4CL1, 4CL2,
4CL4), in addition to a number of genes known to be
involved in formation of lignin and phenolic esters.
Since these results are in good agreement with a
previous study on expression correlation in plants [36],
the following genes for the pathway towards naringenin
were selected for heterologous expression in S. cerevisiae:
the flavonoid biosynthetic genes 4CL3 (at1g65060), CHS1
(at4g00040) and CHI1 (at5g05270), as well as, C4H
(at2g30490) and PAL1 (at2g37040) from the ligninTable 1 A. thaliana genes included in the expression
correlation studies
Gene Gene product A. thaliana locus
PAL1 phenylalanine ammonia lyase at2g37040
PAL2 phenylalanine ammonia lyase at3g53260
PAL3 phenylalanine ammonia lyase at5g04230
PAL4 phenylalanine ammonia lyase at3g10340
C4H trans-cinnamate 4-monooxygenase at2g30490
4CL1 4-coumaric acid-CoA ligase at1g51680
4CL2 4-coumaric acid-CoA ligase at3g21240
4CL3 4-coumaric acid-CoA ligase at1g65060
4CL4 4-coumaric acid-CoA ligase at3g21230
CHS1 Chalcone synthase at4g00040
CHS2 Chalcone synthase at4g34850
CHS3 Chalcone synthase at5g13930
CHI1 Chalcone isomerase at5g05270
CHI2 Chalcone isomerase at3g63170
CHI3 Chalcone isomerase at3g55120
F3H Flavanone 3-hydroxylase at3g51240
FLS Flavonol synthase at5g08640
HCT Quinate O-hydroxycinnamoyltransferase at5g48930
CCoOMT Caffeoyl-CoA 3-O-methyltransferase at4g34050
C3H p-coumaric acid 3-hydroxylase at2g40890
Bold letters indicate genes used in the construction of engineered S. cerevisiae
strains.biosynthetic genes [37]. PAL1 and CHI1 were preferred
over PAL2 and CHI3, as their expression profiles showed
stronger correlations with C4H and 4CL3 respectively
(Figure 2).
Construction and evaluation of a naringenin producing
strain
To enable naringenin production in S. cerevisiae, one
episomal and one integrative expression vector were con-
structed which together, harbor the five flavonoid biosyn-
thetic genes. Additionally, activation of the cytochrome
P450 C4H requires a cytochrome P450 reductase (CPR).
To choose the best candidate gene, the two A. thaliana
CPR variants (CPR1 or CPR2) were separately included
in the pathway engineering strategy. First, the centromericFigure 2 Co-expression analysis of candidate genes for
flavonoid biosynthesis in A. thaliana. Correlations between the
expression of a set of target genes (see Table 1) were established by
bioinformatic analysis of 392 A. thaliana transcriptome datasets [34].
Circles represent genes as described in Table 1. Light grey circles
represent genes where the expression correlates with that of genes
involved in lignin metabolism (represented by C3H, HCT, CCoOMT),
dark grey circles represent genes with expression correlating with
genes of the flavonoid pathway (represented by FLS, F3H and
several UGTs). White circles represent genes with expression profiles
which do not correlate with genes involved in either the lignin or
the flavonoid pathway. Solid lines represent Pearson correlations of
expression above 0.7, dotted lines represent Pearson correlations
between 0.6 and 0.7.
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codon-optimized versions of the A. thaliana C4H (coC4H)
and CPR1 (coCPR1) genes was constructed. In a same
manner, separate construct, PAL1 and coC4H were com-
bined with the coCPR2 gene. Subsequently, the integra-
tion plasmid pUDI065 was constructed, which carried
the non yeast optimized A. thaliana genes at4CL3,
atCHS1 and atCHI1. Only the, C4H and CPR1 in the
naringenin production pathway were codon optimized
since these genes hold the majority of rare codons for
yeast (8), compared to the other genes (PAL1, 4CL3,
CHS3 and CHI1) (3). When coCPR2 was expressed in-
stead of coCPR1, significantly lower naringenin titers
were observed (data not shown); coCPR2 was therefore
not used in further experiments. Introduction of the
coCPR1 version of the centromeric expression vector and
the integration vector yielded the S. cerevisiae strain
IMU011. In shake-flask cultures containing synthetic
medium and with glucose as the sole carbon source, this
strain produced naringenin to a concentration of 5.4 μM
(Figure 3A). Interestingly, naringenin was measured
extracellularly, although its export mechanism has not
yet been elucidated.
Alleviation of tyrosine feedback inhibition of yeast
3-deoxy-D-arabinose-heptulosonate-7-phosphate
(DAHP) synthase
Since phenylalanine is a key intermediate in naringenin
biosynthesis (Figure 1), further metabolic engineering
was directed at improving its intracellular availability.
Aromatic amino acid biosynthesis in S. cerevisiae is sub-
ject to strong feedback inhibition by phenylalanine and
tyrosine. Introduction of a tyrosine insensitive ARO4 allele
(ARO4G226S) [38,39] in conjunction with the deletion of
the other allele of the 3-deoxy-d-arabinose-heptulosonate-
7-phosphate (DAHP) synthase (ARO3) has previously
been shown to cause a 4-fold increase in flux through theFigure 3 Naringenin production in S. cerevisiae. A) Increase in heterolo
engineered strains. (○) IMU011 (atPAL1↑, coC4H↑, coCPR1↑, atCHI1↑, atCHS3
atCHI1↑, atCHS3↑, at4CL3↑), (□) IMX185 (aro3Δ ARO4G226S pdc5Δ, pdc6Δ, atP
(aro3Δ ARO4G226S aro10Δ, pdc5Δ, pdc6Δ, atPAL1↑, coC4H↑, coCPR1↑, atCHI1↑
CEN.PK2-1C. Cultures were grown in shake flasks on synthetic medium con
the auxotrophic requirements of the strains. All cultures were performed inaromatic amino acid pathway [40]. To test the potential
impact of this genetic intervention on naringenin synthesis,
S. cerevisiae strain IMX183 (ARO4G226S aro3Δ, atPAL1↑,
coC4H↑, coCPR1↑, atCHI1↑, atCHS3↑, at4CL3↑) was
constructed. The deregulation of DAHP synthase in this
strain lead to a 2-fold increase of the naringenin titer
in shake flask cultures (10.4 μM) (Figure 3). However,
this increase was accompanied by a strongly enhanced
accumulation of phenylethanol, whose extracellular con-
centration was increased 100-fold to a level ca. 20 fold
higher than the improved naringenin concentration
(Figure 3B). Therefore, to improve further naringenin
production, we adopted a strategy to reduce the diversion
of aromatic amino acid biosynthesis into this byproduct.
Elimination of competing phenylpyruvate decarboxylase
activity
In S. cerevisiae, phenylethanol is produced via the Ehrlich
pathway. Decarboxylation of phenylpyruvate, the 2-oxo
acid associated to phenylalanine, yields phenylacetalde-
hyde, which is subsequently reduced into phenylethanol
and/or oxidized to phenylacetate [41-43]. Decarboxyl-
ation of phenylpyruvate can be catalyzed by four different
thiamine pyrophosphate-dependent 2-oxo acid decarbox-
ylases encoded by ARO10, PDC1, PDC5, and PDC6
[43,44]. Recent work in our group has demonstrated that,
among the four decarboxylases capable of phenylpyru-
vate decarboxylase, Pdc1 and Pdc6 showed a much lower
affinity and decarboxylation rate of phenylpyruvate than
Pdc5 and, in particular, Aro10 [44]. Since absence of all
three pyruvate decarboxylase genes (PDC1, PDC5 and
PDC6) abolishes growth on glucose in synthetic media,
strains only retaining PDC1 (aro10Δ, pcd5Δ, pdc6Δ) were
constructed [45]. The intermediate strain IMX185
(ARO4G226S, aro3Δ, pdc5Δ, pdc6Δ) did not show a
reduced phenylethanol titer compared to its ancestor
IMX183 (ARO4G226S, aro3Δ) (Figure 3B). In contrast, thegous production of naringenin. B) Phenylethanol production in
↑, at4CL3↑), (●) IMX183 (aro3Δ ARO4
G226S atPAL1↑, coC4H↑, coCPR1↑,
AL1↑, coC4H↑, coCPR1↑, atCHI1↑, atCHS3↑, at4CL3↑), (■) IMX106
, atCHS3↑, at4CL3↑), (Δ) non-naringenin producing reference strain
taining 20 g·l-1 glucose and appropriate growth factors to supplement
triplicate. Error bars denote standard deviation.
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pdc5Δ, pdc6Δ, aro10Δ) that also carries the ARO10 dele-
tion exhibited a 22-fold lower concentration of extra-
cellular phenylethanol (44 μM) compared to both
ancestor strains IMX183 and IMX185 (955 μM). This
strong reduction in phenylethanol production coincided
with a 3-fold increase of extracellular naringenin (up to
46.5 μM) (Figure 3A), indicating that reduction of the
flux through the Ehrlich pathway had indeed led to sub-
stantial improvement in naringenin production. Analysis
of culture supernatants revealed that strain IMX106
also produced coumaric acid up to a concentration of
200 μM (Figure 4). Moreover, this strain showed
increased production of another aromatic metabolite
that, based on HPLC spectra and LC-MS analysis, was
identified as phloretic acid (Figure 4). Production of
phloretic acid was only observed in cultures that also
produced coumaric acid and which expressed 4CL3 (data
not shown). This suggests that phloretic acid is most
likely produced from coumaroyl-CoA (Figure 4).
Alleviate the bottleneck downstream of coumaric acid
Naringenin chalcone synthase, which catalyzes the for-
mation of chalcone by condensing coumaroyl-CoA with
three molecules of malonyl-CoA, is known to be an
enzyme with low catalytic activity [46]. The transient
accumulation and later reconsumption of coumaric acid
in shake flask cultures suggested that reactions down-
stream of coumaric acid were limiting naringenin pro-
duction. To test whether the capacity of chalcone synthase
was indeed controlling flux through the pathway, two
additional copies of the coCHS3 gene were introduced
into strain IMX106 on an episomal plasmid (pUDE188),Figure 4 Product formation by S. cerevisiae IMX106 (aro3Δ
ARO4G226S aro10Δ, pdc5Δ, pdc6Δ, atPAL1↑, coC4H↑, coCPR1↑,
atCHI1↑, atCHS3↑, at4CL3↑). Formation of naringenin (○),coumaric
acid (●) and phloretic acid (□). Cultures were grown in shake flasks
on synthetic medium containing 20 g·l-1 glucose. All cultures were
performed in triplicate. Error bars denote standard deviation.yielding strain IMX197. The two additional copies
resulted in a 2.5 fold increase in naringenin accumulation
(134.5 μM) in shake flask cultures (Figure 5A), indicating
that coCHS3 was indeed a limiting step in the naringenin
production. Additional coCHS3 copies also caused a
decreased production of phloretic acid (Figure 5B), con-
sistent with the hypothesis that phloretic acid production
occurs when coumaroyl-CoA cannot be efficiently con-
verted to naringenin.
Expression of a tyrosine ammonia lyase leads to
increased naringenin synthesis
The engineered naringenin production pathway directs
carbon via the aromatic amino acid phenylalanine to
coumaric acid through phenylalanine ammonia lyase,
trans-cinnamate 4-monooxygenase and subsequently to
naringenin through the 4-coumaric acid-CoA ligase and
chalcone synthase reactions (Figure 1). Deregulation of
aromatic amino acid synthesis in S. cerevisiae by elimin-
ating feed-back inhibition of DAHP synthase not only
increases intracellular phenylalanine levels, but also the
intracellular concentration of tyrosine [40]. Since S. cere-
visiae cannot interconvert tyrosine and phenylalanine,
this increased intracellular availability of tyrosine could
not be exploited for naringenin production. In other
organisms, deamination of tyrosine by tyrosine ammonia
lyase does provide an alternative route to coumaric acid.
This has previously been shown to increase naringenin
production by E coli when fed with either glucose or
tyrosine [18,20,47]. To investigate the added benefit of
the direct conversion of tyrosine into coumaric acid in
S. cerevisiae IMX197, a cotal1 gene from Rhodobacter
capsulatus was expressed. This R. capsulatus gene was
chosen based on its known high catalytic efficiency for
tyrosine [48]. Integration of this yeast codon-optimized
cotal1 gene resulted in increased naringenin production
in the resulting strain IMX198 (aro3Δ ARO4G226S aro10Δ,
pdc5Δ, pdc6Δ, atPAL1↑, coC4H↑, coCPR1↑, atCHI1↑,
atCHS3↑, coCHS3↑, at4CL3↑, cotal1↑) (Figure 5B), to a
titer of 200 μM in shake-flask cultures. Additionally,
the phloretic acid concentrations in this strain again
increased compared to the parental strain IMX197
(623,9 ± 11,4 μM and 396,1 ± 6,9 respectively), while
the coumaric acid concentrations in cultures of the
two strains remained the same.
Naringenin production in controlled aerobic batch
cultures
To further characterize strain IMX198 (aro3Δ ARO4G226S
aro10Δ, pdc5Δ, pdc6Δ, atPAL1↑, coC4H↑, coCPR1↑,
atCHI1↑, atCHS3↑, coCHS3↑, at4CL3↑, cotal1↑) under
controlled conditions, this strain was cultured in a 2L
batch bioreactor with 20 g·l-1 glucose at pH 5.0
(Figure 6A, B). When S. cerevisiae is grown aerobically in
Figure 5 Stepwise increase in naringenin formation by S cerevisiae. Formation of A) naringenin and B) phloretic acid in the engineered
strains IMX106 (○)(aro3Δ ARO4G226S aro10Δ, pdc5Δ, pdc6Δ, atPAL1↑, coC4H↑, coCPR1↑, atCHI1↑, atCHS3↑, at4CL3↑), IMX197 (●)(aro3Δ ARO4
G226S
aro10Δ, pdc5Δ, pdc6Δ, atPAL1↑, coC4H↑, coCPR1↑, atCHI1↑, atCHS3↑, at4CL3↑, cotal1↑) and IMX198 (□) (aro3Δ ARO4G226S aro10Δ, pdc5Δ, pdc6Δ,
atPAL1↑, coC4H↑, coCPR1↑, atCHI1↑, atCHS3↑, coCHS3↑, at4CL3↑, cotal1↑). Cultures were grown in shake flasks on synthetic medium containing
20 g·l-1 glucose. All cultures were performed in duplicate. Error bar denotes deviation of the mean.
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predominant mode of glucose metabolism [49,50] and is
characterized by a diauxic growth profile. During the glu-
cose consumption phase the specific growth rate of
IMX198 was 0.2 h-1, which is approximately 50% of the
specific growth rate of the reference strain S. cerevisiae
CEN.PK113-7D under the same conditions [51]. Besides
the expected formation of ethanol, a specific naringenin
production rate of 12.545 ± 0.333 μmol.g-1 CDWh
-1 was
obtained. After complete consumption of glucose, a
naringenin titer 148.06 ± 5.67 μM at a naringenin yield
on glucose of 0.002 ± 0.000 (g·g-1) was obtained. When
all the glucose was consumed, ethanol, acetate and
glycerol that were produced during the first phase
were subsequently consumed (Figure 6A). During this
reconsumption phase, naringenin titers increased to
414.63 ± 1.60 μM, indicating that most naringenin is
produced during this second phase (Figure 6B). However,
it must be taken into account that during this recon-
sumption phase, naringenin production is also facilitated
by the presence of available coumarate that was previ-
ously formed during the glucose consumption phase andFigure 6 Product formation of the naringenin-producing strain S. cere
formation were studied in aerobic and pH controlled (pH 5.0) batch culture
representative experiment. A) Concentrations of glucose (○), ethanol (●), a
B) Concentrations of naringenin (▲), coumaric acid (♦) and phloretic acid (also by the higher amount of biomass, compared to the
glucose phase. When only calculating the product yield
over the total glucose and ethanol consumption phase,
a yield of 0.006 ± 0.000 (g·g-1) was obtained, which is
approximately triple of what is obtained during solely
the glucose consumption phase.
In summary, the naringenin production of IMX198 in
a well aerated and pH controlled batch bioreactor culti-
vation required only 38 hours and yielded more than
twice the naringenin titer that was achieved in equivalent
shake flasks cultivations (200 vs. 415 μM).Discussion
The present study, for the first time, demonstrates
de novo production of the key flavonoid intermediate narin-
genin, from glucose, by an engineered S. cerevisiae strain.
Combined expression of the product pathway, codon
optimization, improvement of precursor supply and reduc-
tion of byproduct formation led to concentrations of over
400 μM naringenin in aerobic, glucose-grown batch cul-
tures. These concentrations are over 4-fold higher thanvisiae IMX198 in bioreactors. Growth and extracellular metabolite
s of IMX198 on glucose. The results shown are from a single
cetate (□), glycerol (■) and optical density (OD660) (Δ).
◊).
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ingenin by an engineered E. coli strain [18].
In previous studies on microbial biotransformation of
aromatic precursors to naringenin, the core biosynthetic
pathway for naringenin synthesis (phenylalanine and/or
tyrosine ammonia lyase, trans-cinnamate 4-monooxygenase,
P450 cytochrome reductase, 4-coumaric acid-CoA ligase,
chalcone synthase) was, in most cases, reconstituted by
co-expressing genes from different plants and/or bacteria
[17-19,27,28]. Only one of those studies used naringenin
biosynthetic genes originating from a single donor organ-
ism (A. thaliana), which resulted in the first demonstra-
tion of de novo naringenin biosynthesis in E. coli [20]. In
line with this observation, co-expression of a set of bio-
synthetic genes from A. thaliana, that were selected
based on correlation of in planta expression profiles, was
sufficient for low-level de novo production of naringenin
in S. cerevisiae (Figure 3). The observations that heterol-
ogous co-expression of genes originating from single
plant species is beneficial for naringenin production, sup-
port the hypothesis that maintaining donor specific
protein-protein interactions can improve pathway kinet-
ics and specificity [52]. Besides using genes from a single
plant species, also the recently developed synthetic pro-
tein scaffolds may be used to explore the impact of the
physical association of pathway enzymes [53-55]. The
potential of this approach is illustrated by the recent
demonstration that protein scaffolding in yeast led to a
five-fold increase of the titer of the stilbenoid resveratrol
[55]. The optimized supply of precursors and decreased
production of aromatic byproducts make the yeast
strains developed in this study an interesting models to
explore the impact of pathway topology on flavonoid
production in a heterologous host.
The improvement of naringenin production in this
study followed a typical metabolic engineering approach
consisting of repeated cycles of design, construction, and
analysis [56]. After introduction of the pathway-encoding
genes and observation of low levels of naringenin, allevi-
ation of feedback inhibition of aromatic amino acid bio-
synthesis by phenylalanine and tyrosine further improved
naringenin production. As seen previously [57]. removal
of feedback inhibition also resulted in an overflow of
phenylalanine into the Ehrlich pathway [40] and, conse-
quently, production of phenylethanol as a major bypro-
duct. Restricting the activity of the Ehrlich pathway by
deletion of three decarboxylase-encoding genes strongly
reduced formation of phenylethanol and had a strong
positive impact on naringenin production (Figure 3). Pre-
cursor supply was further improved by expression of a
tyrosine ammonia lyase, which introduced a second
route towards coumarate besides phenylalanine ammonia
lyase. The subsequent introduction of two additional
copies of the A. thaliana CHS3 gene further increasedthe flux from coumaric acid to naringenin (Figure 5B).
This observation may be attributed to the catalytic prop-
erties of CHS3. This enzyme combines 4 substrates (cou-
maroyl CoA and three copies of malonyl CoA) to
synthesise naringenin, and it is well known to exhibit a
very low catalytic activity. Although originating from a
different plant, the catalytic constant kcat of the chalcone
synthase CHS3 from alfalfa is 2 min-1, [58], which is
roughly 25-fold lower than the kcat of the protein pre-
ceding the chalcone synthase in the metabolic pathway,
the coumaroyl-CoA ligase (4CL3) from A.thaliana which
has a kcat of 50 min-1 [23].
In the naringenin-producing S. cerevisiae strains, the
by-product phloretic acid was produced in concentra-
tions similar to those achieved for naringenin. Phloretic
acid production was only produced in cultures that both
accumulated high concentrations of coumaric acid and
expressed A. thaliana 4CL3. Phloretic acid has previ-
ously been detected in engineered S. cerevisiae, but the
mechanism of its formation remains unknown [59]. Even
though it was observed that increasing the flux to narin-
genin by increasing the copy number of the A. thaliana
CHS3 gene, further analysis of the mechanism of phlore-
tic acid production by these engineered S. cerevisiae, e.g.
via systematic gene deletion studies, provides a good op-
portunity to further improve naringenin production. Also
improvement of the provision of malonyl-CoA, a key pre-
cursor for both naringenin production as well as for lipid
production, might further improve naringenin produc-
tion. It has previously been shown that overexpression of
acetyl-CoA carboxylase, which carboxylates acetyl-CoA
to malonyl-CoA, leads to increased production of fatty
acids in the yeast Hansenula polymorpha [60] and of bio-
diesel or 6-methylsalicylic acid production in S. cerevisiae
[61,62]. Moreover, malonyl-CoA synthase in E. coli com-
bined with malonate supplementation, improved bio-
transformation of coumaric acid into flavonoids [63].
Increasing the availability of malonyl-CoA therefore pro-
vides an interesting target for further research.
Demonstration of de novo production of naringenin in
S. cerevisiae represents an important step towards com-
mercial production of plant-derived flavonoids from glu-
cose. Even though commercial production of naringenin
for direct consumer applications will require substantial
further improvement of product yields and titers.
Furthermore, this engineered naringenin-producing
yeast strain provides an attractive platform for expres-
sion of plant-derived pathways that convert naringenin
into other flavonoids, either by reconstruction of indi-
vidual plant pathways or by combinatorial approaches
based on the powerful yeast-based methods for in vivo
recombination [29,64]. Availability of a robust yeast plat-
form for such studies paves the way for identification,
characterization and eventual industrialization of many
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Conclusions
Here we provide the first report on the production of the
flavonoid naringenin from glucose as sole carbon source
using the yeast S. cerevisiae, and the optimization of the
strain to reach a naringenin titer of over 400 μM. Several
obstacles were overcome when expressing a foreign path-
way in S. cerevisiae, which include the choice of enzymes,
the expression systems the optimization of flux and the
inhibition of competing pathways. This study successfully
describes the reduction of the phenyl ethanol side prod-
uct formation. All were done to increase the final titer of
flavonoid production.
This strain may be used as an ideal platform for produc-
tion of a wide variety of flavonoids originating from narin-
genin, thereby facilitating the production, characterization




All strains used in this study (Table 2) are derived from
the S. cerevisiae CEN.PK strain family background [65,66].
Stock cultures were grown at 30°C in 500 ml shake flask
cultures containing 100 ml synthetic medium (according
to [67]) with 20 g·l-1 glucose and appropriate growth fac-
tors to supplement the specific auxotrophic requirements
of the strains [68]. After overnight growth, a final con-
centration of 20% glycerol was added and 1 ml aliquots
were stored at -80°C.
Introduction of chromosomal gene alteration
Plasmids and oligonucleotide primers used in this study
are listed in Tables 2 and 3, respectively. The geneticin
(G418) resistance cassette (KanMX4) was amplified by
using the pUG6 vector as the template [70]. The KanMX4
PCR product was transformed to the appropriate host
(Table 2) using the lithium acetate method [76]. Synthetic
medium agar plates containing 2% glucose and 200 mg·l-1
G418 (Sigma-Aldrich, Zwijdrecht, The Netherlands) and
appropriate growth factors to supplement the auxo-
trophic requirements of the strains, were used to select
for the presence of the KanMX4 gene. The KanMX4
marker was removed by the Cre-loxP recombination sys-
tem using the plasmid pSH47 as described previously [70].
The introduction of a feed-back-insensitive DAHP
synthase activity in S.cerevisiae was accomplished in two
steps. Firstly, the ARO3 allele was deleted in strain CEN.
PK 2.1C using primers ARO3 KO for and ARO3 KO rev
as described above. In this resulting strain, the chromo-
somal ARO4 allele was replaced by the feed-back-
insensitive ARO4G226S allele [38,39]. Genomic DNA ofstrain CEN.PK717.5A was prepared using the genomic
DNA isolation kit (Zymo Research, Orange, CA),
according to the manufacturer’s recommendations. The
ARO4G226S allele was then amplified using primers Aro4
for/Aro4 rev, and transformed. Selection was performed
by screening for tyrosine tolerance by plating on select-
ive agar plates containing synthetic medium, 2% glucose
and 1 g·l-1 tyrosine. The resulting strain was named
IMK328 (Table 2).
Plasmid construction
Plasmid pUDE172 was obtained by transformation-
associated recombination methods as described previ-
ously [29,30,77]. The backbone fragment harboring the
yeast and bacterial origins of replication and markers
was amplified from pAG416GPD-ccdB (Table 2) using
primers FK86/87. Genes were optimized for S. cerevisiae
using the JCat algorithm [78]), based on the A. thaliana
gene sequence. The DNA fragments were synthesized
(Life Technologies, Bleiswijk, The Netherlands) harboring
the yeast codon-optimized genes (codon, promoter, ter-
minator and 2 unique 80 bp flanks that included an EcoRV
sites at each end). The codon-optimized plant genes were
flanked by different promoter and terminator combina-
tions to prevent plasmid instability due to homologous
recombination. Prior to transformation-associated re-
combination, the synthesized fragments were digested
from the cloning vector using EcoRV and gel purified.
The pAG416GPD-ccdB backbone fragment and the 3
gene cassettes atPAL1, coC4H and coCPR were mixed at
a ratio of 1:2:2:2 (50ng :100ng; 100ng: 100ng) and trans-
formed to CEN.PK2-1C. Colonies were selected on glu-
cose synthetic medium plates in the absence of uracil and
checked by multiplex PCR using the primers FK105 –
FK112. After plasmid isolation, retransformation to
E. coli and subsequent plasmid purification, the struc-
ture of the resulting plasmid pUDE172 (Genbank acces-
sion number: JX268037) was verified using restriction
analysis.
The A. thaliana CHI1 gene was amplified using primers
FK7/8 from plasmid pUNI.U21762 (Table 2), and then
agarose gel purified and digested using SpeI and SalI. The
restricted fragment was ligated into an SpeI and SalI line-
arized pAG305-GPD-ccdB plasmid. The A. thaliana 4CL3
gene was amplified using primers FK9/10 from pDZ.4CL3,
purified and then ligated into p426TEF (Table 2) using
SpeI and SalI. Subsequently, the PTEF-at4CL3-TTEF cas-
sette was amplified using primer FK11/12, purified and
ligated into a NaeI digested and FastAP (Thermo Scien-
tific, Etten-Leur, The Netherlands) treated pUDI053, yield-
ing pUDI060. The A. thaliana CHS3 gene was amplified
using primer FK13/14, purified and ligated into p426TPI
(Table 2) using SpeI and XhoI yielding pUDE101. The
PTPI-atCHS3-TADH cassette was amplified using primer
Table 2 Strains and plasmids used in this study
Strain Genotype Source
CEN.PK2-1c MATalpha ura3 his3 leu2 trp1 MAL2-8cSUC2 [69]
CEN.PK717.5A MATa aro3Δ ARO4G226S This study
IMU011 MATalpha ura3 his3 leu2 trp1 MAL2-8cSUC2, pUDE172, PYK2::pUDI065 This study
IMK328 MATalpha ura3 his3 leu2 trp1 MAL2-8cSUC2 Δaro3(46,1065)::loxP ARO4G226S This study
IMK389 IMK328 pdc6Δ(-6,-2)::loxP pdc5Δ(-6,-2)::loxP This study
IMK393 IMK389 aro10Δ(-6,-2)::loxP This study
IMX183 IMK328 pUDE172, PYK2::pUDI065 This study
IMX185 IMK389 pUDE172, PYK2::pUDI065 This study
IMX106 IMK393 pUDE172, PYK2::pUDI065 This study
IMX193 IMK393 pUDE172, PYK2::pUDI065, TRP1::pUDI069 This study
IMX197 IMK393 pUDE172, PYK2::pUDI065, pUDE188 This study
IMX198 IMK393 pUDE172, PYK2::pUDI065, TRP1::pUDI069, pUDE188 This study
Plasmids
pUG6 PCR template for loxp-KanMX4-loxp cassette [70]
pSH47 Centromeric plasmid, URA3, PGAL1-Cre-TCYC1 [70]
pAG416GPD-ccdB Centromeric plasmid, URA3, PTDH3-ccdb-TCYC1, Addgene plasmid 14148 [71]
pAG306GPD-ccdB Integration plasmid, URA3, PTDH3-ccdb-TCYC1, Addgene plasmid 14140 [71]
pAG305GPD-ccdB Integration plasmid, LEU2, PTDH3-ccdb-TCYC1, Addgene plasmid 14138 [71]
pAG304GPD-ccdB Integration plasmid, TRP1, PTDH3-ccdb-TCYC1, Addgene plasmid 14136 [71]
pAG423GPD-ccdB 2 μm ori, HIS3, PTDH3-ccdb-TCYC1, Addgene plasmid 14150 [71]
p426TEF 2 μm ori, URA3, PTEF –TTEF [72]
p426TPI 2 μm ori, URA3 PTPI –TADH [73]
pUNI.U21762 Cloning vector, Ka, atCHS3 cDNA# [74]
pUNI.U11924 Cloning vector, Ka, atCHI1 cDNA [74]
pDZ.4CL3 Cloning vector, Bla, at4CL3 cDNA [75]
pUD168 pMA cloning vector, Bla, A-PTDH3-atPAL1-TCYC1-B
* This study
pUD169 pMA cloning vector, Bla, B-PPGI-coCPR1-TPGI-C This study
pUD170 pMA cloning vector, Bla, C-PTPI-coC4H-TADH-D This study
pUD175 pMA cloning vector, Bla, E-PPGK-coCHS3-TPGK-F This study
pUDE185 2 μm ori, HIS3, PTDH3-coCHS3-TCYC1 This study
pUDE186 2 μm ori, URA3, PTEF-coCHS3-TTEF This study
pUDE188 2 μm ori, HIS3, PTDH3-coCHS3-TCYC1, PTEF-coCHS3-TTEF This study
pUDE103 2 μm ori, URA3, PTEF-at4CL3-TTEF This study
pUDE172 Centromeric plasmid, URA3, PTDH3-atPAL1-TCYC1, PTPI-coC4H-TADH, PPGI-coCPR1-TPGI This study
pUDI053 Integration plasmid, LEU2, PTDH3-atCHI1-TCYC1 This study
pUDI060 Integration plasmid, LEU2, PTDH3-atCHI1-TCYC1, PTEF-at4CL3-TTEF This study
pUDI061 Integration plasmid, LEU2, PTDH3-atCHI1-TCYC1, PTPI-atCHS3-TADH, PTEF-at4CL3-TTEF This study
pUDI065 Integration plasmid, LEU2, PTDH3-atCHI1-TCYC1, PTPI-atCHS3-TADH, PTEF-at4CL3-TTEF, PYK2(1-710) This study
pUDI069 Integration plasmid, TRP1, PTDH3-coTAL1-TCYC1 This study
* co: codon optimized, #; at: A. thaliana.
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fragment was ligated into SacI digested and FastAP trea-
ted pUDI060 plasmid, yielding pUDI061. A fragment of
the PYK2 gene (1-710bp) was amplified from the CEN.PK2-1C genome using primer FK29/30, and then purified
and digested using PfoI. This fragment was ligated into
pUDI061 plasmid that had been digested by PfoI and
treated with alkaline phosphatase (FastAP, Thermo




ARO3 KO for ATGTTCATTAAAAACGATCACGCCGGTGACAGGAAA-
CGCTTGGAAGACTGCAGCTGAAGCTTCGTACG
ARO3 KO rev CTATTTTTTCAAGGCCTTTCTTCTGTTTCTAACACCTTCT-
GCCAATAGCTGCATAGGCCACTAGTGGATCTG
PDC5 KO for CATAATCAATCTCAAAGAGAACAACACAATACAATAA-
CAAGAAGAACAAACAGCTGAAGCTTCGTACGC
PDC5 KO rev AAAGTAAAAAAATACACAAACGTTGAATCATGAGTTTT-
ATGTTAATTAGCGCATAGGCCACTAGTGGATCTG
PDC6 KO for GGCGGCTGTTTGAAGCCATTCTATCTTAATCTTGTGCT-
ATTGCAGTCCTCCAGCTGAAGCTTCGTACGC
PDC6 KO rev GTAAGTTTTATTTGCAACAATAATTCGTTTGAGTACACT-
ACTAATGGCGCATAGGCCACTAGTGGATCTG
ARO10 KO for GATACTCAAAACAAGTTGACGCGACTTCTGTAAAGTTT-
ATTTACAAGATAACAAAGAAACTCCCTTAAGCCAGCT-
GAAGCTTCGTACGC
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ber: JX268039). The resulting plasmid was linearized
using NcoI and integrated into the chromosomal PYK2
locus.
The tal1 gene from R. capsulatus [48,79], was codon
optimized for yeast using JCat [78], and synthesized
(GeneScript, Piscataway, NJ). The synthetic cotal1 was
amplified using primers FK52/53 and ligated into
pAG304-ccdB using SpeI and XhoI resulting in pUDI069
(Genbank accession number: JX268036). Integration of
this plasmid into the trp1 locus was preceded by
linearization using EcoRV.
A DNA fragment containing the custom-synthesized,
yeast codon-optimized CHS3 sequence (Life Technologies,
Bleiswijk, The Netherlands) was amplified using primers
FK169/170 and ligated into both a pAG325GPD-ccdB and
p426TEF (Table 2) using SpeI and XhoI yielding respect-
ively, pUDE185 and 186. Subsequently, the PTEF-coCHS3-
TTEF cassette was amplified using primers FK 171/172
and restricted using SacI. This cassette was ligated into a
SacI digested and FastAP (Thermo Scientific) treated
pUDE185. Plasmids were screened for opposing gene
orientation by restriction analysis, yielding pUDE188
(Genbank accession number: JX268038).
Molecular biology procedures
PCR amplification was performed using PhusionW Hot
Start II High Fidelity Polymerase (Thermo Scientific)
according to the manufacturer's instructions in a Biometra
TGradient Thermocycler (Biometra, Gottingen, Germany).
Agarose gel separation was performed using 1% (w/v)
agarose (Sigma-Aldrich, Zwijdrecht, The Netherlands)
gel in 1×TAE (40 mM Tris-acetate pH 8.0 and 1 mM
EDTA). Isolation of agarose trapped fragments was per-
formed using Zymoclean Gel DNA Recovery kit (Zymo
Research, Orange, CA). Restriction endonucleases, DNA
ligases and FastAP (Thermo Scientific) were used accord-
ing to the manufacturer's instructions. Transformation
and amplification of plasmids were performed in E. coli
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according to the manufacturer's instructions. Plasmids
were isolated from E. coli with the Sigma GenElute
Plasmid Miniprep Kit (Sigma-Aldrich). Alternatively,
plasmid purification was performed using a ZymoprepTM
Yeast Plasmid Miniprep (Zymo Research). Sequencing of
constructs was performed by Baseclear BV (Baseclear,
Leiden, The Netherlands).
Cultivation and media
E. coli was grown at 37°C in Luria Broth medium con-
taining the appropriate antibiotic, 100 μg·l-1 ampicillin
or 50 μg·l-1 kanamycin (Sigma-Aldrich, Zwijndrecht, The
Netherlands). S. cerevisiae was grown at 30°C in medium
containing demineralized water, 20 g·l-1 glucose, 5 g·l-1
(NH4)2SO4, 3 g·l
-1 KH2PO4, 0.5 g·l
-1 MgSO4.7H2O, vita-
mins and trace elements [67]. The pH of the medium
was set to 6.0 using KOH. Appropriate growth factors to
supplement the auxotrophic requirements of the strains
were added at 150 mg·l-1 for uracil, 500 mg·l-1 for leucine,
75 mg·l-1 for tryptophan and 125 mg·l-1 for histidine [68].
Unless otherwise stated, cultures were grown in 500 ml
shake flasks with 100 ml medium by adding 1 ml frozen
stock culture and incubating at 30°C in an Innova incu-
bator shaker (New Brunswick Scientific, Edison, NJ) set
at 200 rpm. Controlled aerobic batch cultures were
grown at 30°C in 2l bioreactors (Applikon, Schiedam,
The Netherlands), using a working volume of 1l. In the
bioreactor experiments, the (NH4)2SO4 concentration in
the synthetic medium was increased to 10 g·l-1 to avoid
nitrogen depletion towards the end of the culture.
Emulsion C antifoam at 0.05% (w/v) (Sigma-Aldrich,
Zwijndrecht, The Netherlands) was added separately
after autoclaving. The pH was maintained at pH 5.0 by
automatic addition of either 2 M KOH or 2 M H2SO4,
the stirrer speed was fixed at 800 rpm and the aeration
rate was set at 500 ml·min-1.
Analytical methods
Optical density was measured at 660 nm using a Libra S11
spectrophotometer (Biochrom, Cambridge, UK). Biomass
dry weights were determined by filtration of 10 ml culture
over dry, preweighed 0.45 μm nitrocellulose filters (Gelman
Laboratory, Ann Arbor, USA). After removal of the
medium, the filter was washed twice with demineralized
water and dried for 20 min using a microwave set at 350
W. Glucose, ethanol, glycerol and acetate were analyzed
using an Aminex HPX-87H ion exchange column (BioRad,
Veenendaal, The Netherlands) operated at 60°C with 5 mM
H2SO4 as mobile phase at a flow rate of 0.6 ml·min
-1. For
measurement of phenylpropanoic compounds, culture
samples were diluted with an equal volume of 100% etha-
nol. After vigorous mixing, cells were spun down at 13000
rpm in a Sorval Heraeus #3328 rotor for 2 min. Thesupernatant was analysed using HPLC. For phenylpropa-
noic compounds, measurements were made using a Waters
2695 separation module and a Waters 996 photodiode
array detector. Phloretic acid, coumaric acid, phenyl
ethanol, cinnamic acid and naringenin were measured re-
spectively at 275, 309, 214, 277, 289 nm using an Agilent
Zorbax SB-C18 Column (4.6 × 5.0, 3.5 micron) operating at
30oC. A gradient of acetonitrile and 20 mM KH2PO4 (pH
2) with 1% acetonitrile was used as eluent, at a flow rate of
1 ml·min-1, increasing from 0 to 10% acetonitrile in 6 min
followed by an increase to 40% acetonitrile until 23 min.
From 23 min to 27 min, the flow was set to 100% KH2PO4.
Naringenin, coumaric acid, cinnamic acid, phloretic acid
and phenylethanol standards were obtained from Sigma
Aldrich (Sigma-Aldrich, Zwijndrecht, The Netherlands).
For analysis of carbon dioxide production in bioreactor
cultures, the off-gas was first cooled in a condenser
(2°C) and dried with a Perma Pure Dryer (Permapure,
Toms River, NJ). CO2 concentrations in the off-gas were
then measured with a NGA 2000 Rosemount gas
analyzer (Rosemount Analytical, Orrville,OH).
Identification of phenylpropanoid intermediates and
naringenin was performed using liquid chromatog-
raphy coupled to both photodiode-array detection and
accurate mass quadrupole time-of-flight mass spec-
trometry (LC–PDA-QTOF MS) was performed using
a Waters Alliance 2795 HPLC connected to a Waters
2996 PDA detector and subsequently a QTOF Ultima
V4.00.00 mass spectrometer (Waters, MS technolo-
gies, UK) operating in negative ionization mode, an
analytical column (Luna 3 μ C18/2 100A; 2.0 × 150
mm) attached to a C18 pre-column (2.0 × 4 mm;
AJO-4286; both Phenomenex, USA). Eluents A (ultra-
pure water:formic acid (1000:1, v/v) ) and B (aceto-
nitrile : formic acid (1000 : 1, v/v) ) were used at
0.19 ml.min. The gradient started at 5% B and
increased linearly to 35% B in 45 min, after which
the column was washed and equilibrated for 15 min
before the next injection. The injection volume was 5
μl. Leucine enkephalin ([M-H]- = 554.2620) was used
as a lock mass for on-line accurate mass correction
[80]. Data were recorded using MassLynx 4.0 software
(Waters).Co-expression correlation analysis of naringenin
biosynthetic genes in A. thaliana
Expression correlation analysis was performed using the
BAR Expression Angler [35]. Each candidate gene listed in
Table 1 was used as “bait”, and expression was correlated
over a set of 392 micro-array experiments generated using
the ATH1 Affymetrix Whole Genome GeneChip, from the
Nottingham Arabidopsis Stock Centre's microarray data-
base [34]. Correlations between expression levels of genes
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coefficient was above 0.6.
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